DHODH-IN-23

DHODH-IN-23 (Compound A) is an orally active DHODH inhibitor that can be used for the research of cancer[1].

Product Specifications

CAS Number

[1346705-53-0]

UNSPSC

12352005

Hazard Statement

H302, H315, H319

Target

Dihydroorotate Dehydrogenase

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/dhodh-in-23.html

Purity

98.75

Solubility

DMSO : 125 mg/mL (ultrasonic)

Smiles

O=C(C1=C(C(NC2=C(C=C(C3=CC=CC(OCCCC)=C3)C=C2Cl)F)=O)C=CC=C1)O

Molecular Formula

C24H21ClFNO4

Molecular Weight

441.88

Precautions

H302, H315, H319

References & Citations

[1]Srikant Viswanadha, et al. Compositions comprising a dhodh inhibitor for the treatment of acute myeloid leukemia. Patent WO2021079273A1.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

132304-ML750 100 µL

RAP2B (Ras-related Protein Rap-2b, MGC20484) (MaxLight 750) discontinued

Ask

View Details

TP721465 10 µg

AGTR1 Human Recombinant Protein, Synthetic Nanodisc

Ask

View Details

abx060605 50 µg

Influenza A N1 (Swine) Peptide Protein

Ask

View Details

abx704575-01 100 mL

Complete Medium for Rat Osteocyte Cells

Ask

View Details

abx704575-02 500 mL

Complete Medium for Rat Osteocyte Cells

Ask

View Details

NBP3-14114F 0.1 mL

Mouse Monoclonal Lysozyme Antibody (LYZ/3942) [FITC]

Ask

View Details